SLC6A3 and Parkinson disease: In conclusion, we demonstrated that dopamine transporter levels are lower in FTD than in healthy subjects, and that striatal dopaminergic loss in FTD shows a more uniform distribution across the putamen and caudate, differing from the posterior-to-anterior gradient typically observed in Parkinson’s disease.